

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.56847529 |
| 2 | regulation of vitamin metabolic process (GO:0030656) | 4.02382667 |
| 3 | adhesion of symbiont to host cell (GO:0044650) | 3.90600963 |
| 4 | virion attachment to host cell (GO:0019062) | 3.90600963 |
| 5 | low-density lipoprotein particle clearance (GO:0034383) | 3.75672913 |
| 6 | * positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.69090388 |
| 7 | adhesion of symbiont to host (GO:0044406) | 3.65671321 |
| 8 | regulation of early endosome to late endosome transport (GO:2000641) | 3.63991979 |
| 9 | protein localization to endosome (GO:0036010) | 3.63810713 |
| 10 | positive regulation of extracellular matrix organization (GO:1903055) | 3.61404021 |
| 11 | apoptotic cell clearance (GO:0043277) | 3.60972788 |
| 12 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.52573958 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 3.48632368 |
| 14 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.48589070 |
| 15 | barbed-end actin filament capping (GO:0051016) | 3.46374744 |
| 16 | * regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.38832239 |
| 17 | regulation of mononuclear cell migration (GO:0071675) | 3.36287592 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.30770295 |
| 19 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.27878773 |
| 20 | protein carboxylation (GO:0018214) | 3.23412670 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.23412670 |
| 22 | cell adhesion mediated by integrin (GO:0033627) | 3.11762501 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.11635308 |
| 24 | lysine metabolic process (GO:0006553) | 3.09011113 |
| 25 | lysine catabolic process (GO:0006554) | 3.09011113 |
| 26 | hyaluronan catabolic process (GO:0030214) | 3.07494773 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 3.06537581 |
| 28 | stress fiber assembly (GO:0043149) | 3.06088490 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 3.04653056 |
| 30 | urea cycle (GO:0000050) | 3.04063149 |
| 31 | urea metabolic process (GO:0019627) | 3.04063149 |
| 32 | plasma lipoprotein particle clearance (GO:0034381) | 3.03575351 |
| 33 | regulation of cholesterol storage (GO:0010885) | 3.02826656 |
| 34 | regulation of cholesterol homeostasis (GO:2000188) | 3.00639858 |
| 35 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.00034383 |
| 36 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.99366801 |
| 37 | cysteine metabolic process (GO:0006534) | 2.98458615 |
| 38 | Golgi transport vesicle coating (GO:0048200) | 2.96854475 |
| 39 | COPI coating of Golgi vesicle (GO:0048205) | 2.96854475 |
| 40 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.93367324 |
| 41 | decidualization (GO:0046697) | 2.91860474 |
| 42 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.91738376 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.90709895 |
| 44 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.88745451 |
| 45 | regulation of extracellular matrix disassembly (GO:0010715) | 2.86182003 |
| 46 | endodermal cell differentiation (GO:0035987) | 2.85490467 |
| 47 | growth hormone receptor signaling pathway (GO:0060396) | 2.85376273 |
| 48 | lipoprotein metabolic process (GO:0042157) | 2.82100393 |
| 49 | glycosphingolipid catabolic process (GO:0046479) | 2.81557441 |
| 50 | pinocytosis (GO:0006907) | 2.81533632 |
| 51 | skin morphogenesis (GO:0043589) | 2.79618471 |
| 52 | response to laminar fluid shear stress (GO:0034616) | 2.78763887 |
| 53 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.78709394 |
| 54 | homocysteine metabolic process (GO:0050667) | 2.78475439 |
| 55 | regulation of protein activation cascade (GO:2000257) | 2.75449571 |
| 56 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.74123672 |
| 57 | oligosaccharide catabolic process (GO:0009313) | 2.74089465 |
| 58 | hypotonic response (GO:0006971) | 2.73309775 |
| 59 | regulation of chemokine biosynthetic process (GO:0045073) | 2.72822198 |
| 60 | regulation of fibrinolysis (GO:0051917) | 2.72181034 |
| 61 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.71652389 |
| 62 | L-phenylalanine metabolic process (GO:0006558) | 2.71652389 |
| 63 | substrate-dependent cell migration (GO:0006929) | 2.70556898 |
| 64 | regulation of complement activation (GO:0030449) | 2.69510239 |
| 65 | keratan sulfate catabolic process (GO:0042340) | 2.69494397 |
| 66 | epoxygenase P450 pathway (GO:0019373) | 2.68912033 |
| 67 | negative regulation of lipid transport (GO:0032369) | 2.68740423 |
| 68 | nitrogen cycle metabolic process (GO:0071941) | 2.68674569 |
| 69 | 4-hydroxyproline metabolic process (GO:0019471) | 2.68005855 |
| 70 | complement activation, alternative pathway (GO:0006957) | 2.67242396 |
| 71 | L-phenylalanine catabolic process (GO:0006559) | 2.66392773 |
| 72 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.66392773 |
| 73 | glyoxylate metabolic process (GO:0046487) | 2.64175044 |
| 74 | negative regulation of fatty acid transport (GO:2000192) | 2.63889344 |
| 75 | positive regulation of lipid catabolic process (GO:0050996) | 2.63353788 |
| 76 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.62735567 |
| 77 | regulation of triglyceride catabolic process (GO:0010896) | 2.61089291 |
| 78 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.60685389 |
| 79 | kynurenine metabolic process (GO:0070189) | 2.60669642 |
| 80 | fibrinolysis (GO:0042730) | 2.58975543 |
| 81 | negative regulation of sterol transport (GO:0032372) | 2.58973414 |
| 82 | negative regulation of cholesterol transport (GO:0032375) | 2.58973414 |
| 83 | intestinal cholesterol absorption (GO:0030299) | 2.58183093 |
| 84 | collagen metabolic process (GO:0032963) | 2.57894871 |
| 85 | positive regulation of p38MAPK cascade (GO:1900745) | 2.57691695 |
| 86 | endocytic recycling (GO:0032456) | 2.56515767 |
| 87 | phospholipid homeostasis (GO:0055091) | 2.55692606 |
| 88 | glycolipid catabolic process (GO:0019377) | 2.55514075 |
| 89 | response to thyroid hormone (GO:0097066) | 2.55462965 |
| 90 | aromatic amino acid family catabolic process (GO:0009074) | 2.55035761 |
| 91 | high-density lipoprotein particle remodeling (GO:0034375) | 2.52941704 |
| 92 | basement membrane organization (GO:0071711) | 2.51884256 |
| 93 | regulation of extracellular matrix organization (GO:1903053) | 2.51549529 |
| 94 | regulation of podosome assembly (GO:0071801) | 2.51249603 |
| 95 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.50644684 |
| 96 | regulation of plasminogen activation (GO:0010755) | 2.48998394 |
| 97 | fibril organization (GO:0097435) | 2.48397179 |
| 98 | amino-acid betaine metabolic process (GO:0006577) | 2.47754008 |
| 99 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.47745161 |
| 100 | positive regulation of blood coagulation (GO:0030194) | 2.47670217 |
| 101 | positive regulation of hemostasis (GO:1900048) | 2.47670217 |
| 102 | negative regulation of focal adhesion assembly (GO:0051895) | 2.47284040 |
| 103 | negative regulation of cell junction assembly (GO:1901889) | 2.47284040 |
| 104 | negative regulation of adherens junction organization (GO:1903392) | 2.47284040 |
| 105 | collagen catabolic process (GO:0030574) | 2.46737684 |
| 106 | epithelial cell-cell adhesion (GO:0090136) | 2.46657024 |
| 107 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.46152126 |
| 108 | cell-substrate junction assembly (GO:0007044) | 2.45902762 |
| 109 | reverse cholesterol transport (GO:0043691) | 2.45144116 |
| 110 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.44951329 |
| 111 | collagen fibril organization (GO:0030199) | 2.44730227 |
| 112 | NIK/NF-kappaB signaling (GO:0038061) | 2.44681504 |
| 113 | negative regulation of lipid storage (GO:0010888) | 2.44521531 |
| 114 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.43453053 |
| 115 | phospholipid efflux (GO:0033700) | 2.42713855 |
| 116 | regulation of fever generation (GO:0031620) | 2.41927917 |
| 117 | valine metabolic process (GO:0006573) | 2.41921597 |
| 118 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.41559084 |
| 119 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.41559084 |
| 120 | plasma lipoprotein particle assembly (GO:0034377) | 2.41112540 |
| 121 | cellular response to growth hormone stimulus (GO:0071378) | 2.39817218 |
| 122 | embryo implantation (GO:0007566) | 2.39621922 |
| 123 | negative regulation of anoikis (GO:2000811) | 2.38982503 |
| 124 | indole-containing compound catabolic process (GO:0042436) | 2.38351067 |
| 125 | indolalkylamine catabolic process (GO:0046218) | 2.38351067 |
| 126 | tryptophan catabolic process (GO:0006569) | 2.38351067 |
| 127 | wound healing, spreading of epidermal cells (GO:0035313) | 2.38205783 |
| 128 | positive regulation of fatty acid oxidation (GO:0046321) | 2.38091433 |
| 129 | intestinal absorption (GO:0050892) | 2.36442581 |
| 130 | chondrocyte proliferation (GO:0035988) | 2.35843327 |
| 131 | positive regulation of coagulation (GO:0050820) | 2.35737199 |
| 132 | protein heterotrimerization (GO:0070208) | 2.35367777 |
| 133 | cell migration involved in heart development (GO:0060973) | 2.35334937 |
| 134 | multicellular organismal catabolic process (GO:0044243) | 2.35278291 |
| 135 | myeloid dendritic cell differentiation (GO:0043011) | 2.35132039 |
| 136 | response to growth hormone (GO:0060416) | 2.34988630 |
| 137 | regulation of macrophage chemotaxis (GO:0010758) | 2.34458080 |
| 138 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.34316638 |
| 139 | multicellular organismal metabolic process (GO:0044236) | 2.34044766 |
| 140 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.33883775 |
| 141 | sterol homeostasis (GO:0055092) | 2.33596913 |
| 142 | 2-oxoglutarate metabolic process (GO:0006103) | 2.33308893 |
| 143 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.33101271 |
| 144 | COPII vesicle coating (GO:0048208) | 2.32478391 |
| 145 | positive regulation of receptor recycling (GO:0001921) | 2.32203001 |
| 146 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.32191930 |
| 147 | cellular response to arsenic-containing substance (GO:0071243) | 2.32044556 |
| 148 | positive regulation of heat generation (GO:0031652) | 2.31261733 |
| 149 | embryonic process involved in female pregnancy (GO:0060136) | 2.30850972 |
| 150 | extracellular matrix assembly (GO:0085029) | 2.30823196 |
| 151 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.30753593 |
| 152 | cholesterol homeostasis (GO:0042632) | 2.30575171 |
| 153 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.30283962 |
| 154 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.29910342 |
| 155 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.29321766 |
| 156 | regulation of integrin activation (GO:0033623) | 2.28960119 |
| 157 | tryptophan metabolic process (GO:0006568) | 2.28831003 |
| 158 | urate metabolic process (GO:0046415) | 2.28685543 |
| 159 | positive regulation of lipid storage (GO:0010884) | 2.27650177 |
| 160 | plasma lipoprotein particle remodeling (GO:0034369) | 2.27572420 |
| 161 | protein-lipid complex remodeling (GO:0034368) | 2.27572420 |
| 162 | macromolecular complex remodeling (GO:0034367) | 2.27572420 |
| 163 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.27514203 |
| 164 | cellular glucuronidation (GO:0052695) | 2.27255024 |
| 165 | regulation of p38MAPK cascade (GO:1900744) | 2.26684409 |
| 166 | extracellular matrix disassembly (GO:0022617) | 2.26522794 |
| 167 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.26196647 |
| 168 | drug catabolic process (GO:0042737) | 2.25663398 |
| 169 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.25370653 |
| 170 | membrane raft organization (GO:0031579) | 2.24792708 |
| 171 | mannose metabolic process (GO:0006013) | 2.24398850 |
| 172 | blood vessel maturation (GO:0001955) | 2.24206571 |
| 173 | bile acid biosynthetic process (GO:0006699) | 2.23967174 |
| 174 | hyaluronan metabolic process (GO:0030212) | 2.23964503 |
| 175 | ovulation (GO:0030728) | 2.23581806 |
| 176 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.22343448 |
| 177 | * protein-lipid complex assembly (GO:0065005) | 2.20939465 |
| 178 | pentose-phosphate shunt (GO:0006098) | 2.20866147 |
| 179 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.20434374 |
| 180 | hepatocyte apoptotic process (GO:0097284) | 2.20313835 |
| 181 | acylglycerol homeostasis (GO:0055090) | 2.20049537 |
| 182 | triglyceride homeostasis (GO:0070328) | 2.20049537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.96291073 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.75283273 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.54618176 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.53699406 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.45298077 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.14330790 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.10928276 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.73433632 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.69213768 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.62713134 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.56565495 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.54699521 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.36050691 |
| 14 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.20317296 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20263615 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.09163412 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07351501 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.06619331 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.05638521 |
| 20 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.01821613 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.88214112 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.87384021 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.85878398 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85815186 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76322698 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75845282 |
| 27 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.75736303 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.75335907 |
| 29 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.72058222 |
| 30 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71197732 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.69888052 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68545533 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.67940232 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65589488 |
| 35 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.65588604 |
| 36 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.65194069 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.59725258 |
| 38 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59450580 |
| 39 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.58790545 |
| 40 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.58580702 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58503928 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.53262377 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.52264575 |
| 44 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.52165857 |
| 45 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.50922575 |
| 46 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.48891845 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46296654 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.44334511 |
| 49 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.43385256 |
| 50 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42415689 |
| 51 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.37130879 |
| 52 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.36865206 |
| 53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.36310705 |
| 54 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.35555454 |
| 55 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34818281 |
| 56 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34467461 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.34153745 |
| 58 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.34040014 |
| 59 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.34040014 |
| 60 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32365929 |
| 61 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31547417 |
| 62 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.29198198 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28197773 |
| 64 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26632709 |
| 65 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.26182370 |
| 66 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25381244 |
| 67 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25373887 |
| 68 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24980381 |
| 69 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.24366269 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.24330996 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.23348290 |
| 72 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.22736991 |
| 73 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.22478593 |
| 74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22390530 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22023960 |
| 76 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21946006 |
| 77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20151498 |
| 78 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.17932482 |
| 79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17931321 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17578452 |
| 81 | MAF_26560356_Chip-Seq_TH1_Human | 1.17108297 |
| 82 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.16239717 |
| 83 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15976055 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15954697 |
| 85 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.15048867 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14725305 |
| 87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13988075 |
| 88 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13578018 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13417540 |
| 90 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12781874 |
| 91 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11256162 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08890793 |
| 93 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.08887431 |
| 94 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.07433981 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07341596 |
| 96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07153634 |
| 97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06357869 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06319857 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05095393 |
| 100 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04232801 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.02197615 |
| 102 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01077867 |
| 103 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00773556 |
| 104 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.99336207 |
| 105 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99286030 |
| 106 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99158215 |
| 107 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98677947 |
| 108 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.98092784 |
| 109 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97811019 |
| 110 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.97596290 |
| 111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.97550511 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96711586 |
| 113 | MYB_26560356_Chip-Seq_TH1_Human | 0.96036877 |
| 114 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95282661 |
| 115 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95282661 |
| 116 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95104856 |
| 117 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.94619806 |
| 118 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94229455 |
| 119 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94142555 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93731018 |
| 121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93082581 |
| 122 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92838719 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.89991906 |
| 124 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89487659 |
| 125 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87515500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.00668974 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.88784883 |
| 3 | MP0005360_urolithiasis | 3.76610370 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.15158719 |
| 5 | MP0003252_abnormal_bile_duct | 2.24517255 |
| 6 | MP0009840_abnormal_foam_cell | 2.23644009 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.22627967 |
| 8 | MP0005365_abnormal_bile_salt | 2.17950279 |
| 9 | MP0005275_abnormal_skin_tensile | 2.16126406 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.11412165 |
| 11 | MP0003566_abnormal_cell_adhesion | 2.05326564 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.00614292 |
| 13 | MP0003950_abnormal_plasma_membrane | 1.84050509 |
| 14 | MP0006054_spinal_hemorrhage | 1.80374184 |
| 15 | MP0008004_abnormal_stomach_pH | 1.74075011 |
| 16 | MP0005023_abnormal_wound_healing | 1.73875322 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 1.69108109 |
| 18 | MP0003279_aneurysm | 1.67649091 |
| 19 | MP0001542_abnormal_bone_strength | 1.58441156 |
| 20 | MP0010329_abnormal_lipoprotein_level | 1.56879374 |
| 21 | MP0001958_emphysema | 1.55822568 |
| 22 | MP0005058_abnormal_lysosome_morphology | 1.51173265 |
| 23 | MP0004272_abnormal_basement_membrane | 1.49186250 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.42867674 |
| 25 | MP0005076_abnormal_cell_differentiation | 1.41981491 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.41611866 |
| 27 | MP0001666_abnormal_nutrient_absorption | 1.39459053 |
| 28 | MP0003303_peritoneal_inflammation | 1.38493655 |
| 29 | MP0002877_abnormal_melanocyte_morpholog | 1.38011341 |
| 30 | MP0003091_abnormal_cell_migration | 1.37598662 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.36484394 |
| 32 | MP0003806_abnormal_nucleotide_metabolis | 1.34348393 |
| 33 | MP0003436_decreased_susceptibility_to | 1.32355319 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.31548533 |
| 35 | MP0002060_abnormal_skin_morphology | 1.31331227 |
| 36 | MP0005503_abnormal_tendon_morphology | 1.28888596 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.28627077 |
| 38 | MP0000609_abnormal_liver_physiology | 1.28391107 |
| 39 | MP0010368_abnormal_lymphatic_system | 1.22671360 |
| 40 | MP0000604_amyloidosis | 1.19093509 |
| 41 | MP0005164_abnormal_response_to | 1.18657704 |
| 42 | MP0005409_darkened_coat_color | 1.17399685 |
| 43 | MP0009384_cardiac_valve_regurgitation | 1.17193853 |
| 44 | MP0009785_altered_susceptibility_to | 1.16370962 |
| 45 | MP0005257_abnormal_intraocular_pressure | 1.15745881 |
| 46 | MP0005332_abnormal_amino_acid | 1.15728592 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.13476200 |
| 48 | MP0010307_abnormal_tumor_latency | 1.12244430 |
| 49 | MP0003941_abnormal_skin_development | 1.11265344 |
| 50 | MP0003828_pulmonary_edema | 1.10862919 |
| 51 | MP0005165_increased_susceptibility_to | 1.10190209 |
| 52 | MP0003075_altered_response_to | 1.09521857 |
| 53 | MP0000733_abnormal_muscle_development | 1.08134355 |
| 54 | MP0004947_skin_inflammation | 1.07919123 |
| 55 | MP0000767_abnormal_smooth_muscle | 1.07854070 |
| 56 | MP0001835_abnormal_antigen_presentation | 1.07673435 |
| 57 | MP0003724_increased_susceptibility_to | 1.07618276 |
| 58 | MP0000685_abnormal_immune_system | 1.06283991 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.06207578 |
| 60 | MP0002168_other_aberrant_phenotype | 1.03124704 |
| 61 | MP0005083_abnormal_biliary_tract | 1.03120475 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.02458892 |
| 63 | MP0000598_abnormal_liver_morphology | 1.02142240 |
| 64 | MP0001915_intracranial_hemorrhage | 1.01601649 |
| 65 | MP0004264_abnormal_extraembryonic_tissu | 1.00044591 |
| 66 | MP0004233_abnormal_muscle_weight | 0.98940738 |
| 67 | MP0004858_abnormal_nervous_system | 0.96535925 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 0.96496073 |
| 69 | MP0004019_abnormal_vitamin_homeostasis | 0.95683519 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 0.94983843 |
| 71 | MP0005666_abnormal_adipose_tissue | 0.93934380 |
| 72 | MP0001243_abnormal_dermal_layer | 0.93815056 |
| 73 | MP0005000_abnormal_immune_tolerance | 0.92761118 |
| 74 | MP0001533_abnormal_skeleton_physiology | 0.92653256 |
| 75 | MP0002796_impaired_skin_barrier | 0.92395822 |
| 76 | MP0005451_abnormal_body_composition | 0.92220005 |
| 77 | MP0005595_abnormal_vascular_smooth | 0.91545033 |
| 78 | MP0003195_calcinosis | 0.91298452 |
| 79 | MP0002933_joint_inflammation | 0.90991740 |
| 80 | MP0009053_abnormal_anal_canal | 0.89887389 |
| 81 | MP0005464_abnormal_platelet_physiology | 0.89369294 |
| 82 | MP0003795_abnormal_bone_structure | 0.88604275 |
| 83 | MP0000858_altered_metastatic_potential | 0.87340843 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.85747706 |
| 85 | MP0002254_reproductive_system_inflammat | 0.85714559 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.85359649 |
| 87 | MP0005166_decreased_susceptibility_to | 0.83744652 |
| 88 | MP0002118_abnormal_lipid_homeostasis | 0.83142829 |
| 89 | MP0005387_immune_system_phenotype | 0.83082728 |
| 90 | MP0001790_abnormal_immune_system | 0.83082728 |
| 91 | MP0003045_fibrosis | 0.82846748 |
| 92 | MP0003448_altered_tumor_morphology | 0.82664793 |
| 93 | MP0010155_abnormal_intestine_physiology | 0.81918954 |
| 94 | MP0009278_abnormal_bone_marrow | 0.81436040 |
| 95 | MP0008260_abnormal_autophagy | 0.81351219 |
| 96 | MP0002419_abnormal_innate_immunity | 0.80191392 |
| 97 | MP0001216_abnormal_epidermal_layer | 0.80147073 |
| 98 | MP0002295_abnormal_pulmonary_circulatio | 0.80050176 |
| 99 | MP0005670_abnormal_white_adipose | 0.80027583 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.79109273 |
| 101 | MP0001845_abnormal_inflammatory_respons | 0.76824506 |
| 102 | MP0006082_CNS_inflammation | 0.76736001 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.75290592 |
| 104 | MP0005025_abnormal_response_to | 0.74625462 |
| 105 | MP0002896_abnormal_bone_mineralization | 0.73988867 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.73389740 |
| 107 | MP0008469_abnormal_protein_level | 0.73214311 |
| 108 | MP0005395_other_phenotype | 0.73008157 |
| 109 | MP0000249_abnormal_blood_vessel | 0.72697561 |
| 110 | MP0001545_abnormal_hematopoietic_system | 0.72299869 |
| 111 | MP0005397_hematopoietic_system_phenotyp | 0.72299869 |
| 112 | MP0002452_abnormal_antigen_presenting | 0.72141232 |
| 113 | MP0009763_increased_sensitivity_to | 0.71794427 |
| 114 | MP0003186_abnormal_redox_activity | 0.71668915 |
| 115 | MP0002166_altered_tumor_susceptibility | 0.71520571 |
| 116 | MP0000343_altered_response_to | 0.71510861 |
| 117 | MP0002128_abnormal_blood_circulation | 0.71415703 |
| 118 | MP0001853_heart_inflammation | 0.71384972 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.71214786 |
| 120 | MP0004510_myositis | 0.70669154 |
| 121 | MP0000678_abnormal_parathyroid_gland | 0.70124386 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.69993930 |
| 123 | MP0005390_skeleton_phenotype | 0.69666180 |
| 124 | MP0001756_abnormal_urination | 0.69090678 |
| 125 | MP0001849_ear_inflammation | 0.68747121 |
| 126 | MP0009764_decreased_sensitivity_to | 0.68555179 |
| 127 | MP0005508_abnormal_skeleton_morphology | 0.67935336 |
| 128 | MP0001800_abnormal_humoral_immune | 0.67663898 |
| 129 | MP0005167_abnormal_blood-brain_barrier | 0.67390522 |
| 130 | MP0002135_abnormal_kidney_morphology | 0.66539778 |
| 131 | MP0000371_diluted_coat_color | 0.65501138 |
| 132 | MP0003868_abnormal_feces_composition | 0.64964071 |
| 133 | MP0002113_abnormal_skeleton_development | 0.64409131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.92238474 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.37603229 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.01323762 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.01323762 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.01323762 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.84174773 |
| 7 | Peritonitis (HP:0002586) | 3.66447876 |
| 8 | Myocardial infarction (HP:0001658) | 3.58310514 |
| 9 | Xanthomatosis (HP:0000991) | 3.33904534 |
| 10 | Ankle contracture (HP:0006466) | 3.29903438 |
| 11 | Cerebral aneurysm (HP:0004944) | 3.24420301 |
| 12 | Cervical subluxation (HP:0003308) | 3.23423285 |
| 13 | Aortic dissection (HP:0002647) | 3.06443903 |
| 14 | Vascular tortuosity (HP:0004948) | 3.05372374 |
| 15 | Aortic aneurysm (HP:0004942) | 3.05240805 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.01493949 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.99839198 |
| 18 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.80574471 |
| 19 | Arterial tortuosity (HP:0005116) | 2.78287117 |
| 20 | Spinal rigidity (HP:0003306) | 2.74452833 |
| 21 | Mitral valve prolapse (HP:0001634) | 2.74036964 |
| 22 | Follicular hyperkeratosis (HP:0007502) | 2.73728458 |
| 23 | Intrahepatic cholestasis (HP:0001406) | 2.71914677 |
| 24 | Increased connective tissue (HP:0009025) | 2.66964704 |
| 25 | Shallow orbits (HP:0000586) | 2.65442145 |
| 26 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.62560057 |
| 27 | Osteolytic defects of the hand bones (HP:0009699) | 2.62560057 |
| 28 | Complement deficiency (HP:0004431) | 2.47488527 |
| 29 | Increased mean platelet volume (HP:0011877) | 2.47439418 |
| 30 | Hypobetalipoproteinemia (HP:0003563) | 2.47124559 |
| 31 | Dilatation of the ascending aorta (HP:0005111) | 2.45650251 |
| 32 | Esophageal varix (HP:0002040) | 2.44842876 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44499897 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44499897 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44499897 |
| 36 | Vertebral compression fractures (HP:0002953) | 2.43190675 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.42207719 |
| 38 | Aneurysm (HP:0002617) | 2.37813506 |
| 39 | Hypolipoproteinemia (HP:0010981) | 2.37121331 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 2.36013228 |
| 41 | Nuclear cataract (HP:0100018) | 2.32281720 |
| 42 | Atrophic scars (HP:0001075) | 2.31721224 |
| 43 | Abnormality of proline metabolism (HP:0010907) | 2.30893486 |
| 44 | Hydroxyprolinuria (HP:0003080) | 2.30893486 |
| 45 | Abnormal platelet volume (HP:0011876) | 2.28329353 |
| 46 | Thin bony cortex (HP:0002753) | 2.27439584 |
| 47 | Ulnar bowing (HP:0003031) | 2.26805368 |
| 48 | Axonal loss (HP:0003447) | 2.24922999 |
| 49 | Blue sclerae (HP:0000592) | 2.24827813 |
| 50 | Slender build (HP:0001533) | 2.24662819 |
| 51 | Hematochezia (HP:0002573) | 2.20828548 |
| 52 | Increased variability in muscle fiber diameter (HP:0003557) | 2.19718091 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.18460741 |
| 54 | Achilles tendon contracture (HP:0001771) | 2.18431116 |
| 55 | Abnormality of complement system (HP:0005339) | 2.16570376 |
| 56 | Camptodactyly of toe (HP:0001836) | 2.15585462 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.13984534 |
| 58 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.12469739 |
| 59 | Genu recurvatum (HP:0002816) | 2.12317371 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.12057406 |
| 61 | Mitral stenosis (HP:0001718) | 2.11173500 |
| 62 | Biconcave vertebral bodies (HP:0004586) | 2.10686066 |
| 63 | Broad metatarsal (HP:0001783) | 2.10123211 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 2.09334435 |
| 65 | Soft skin (HP:0000977) | 2.08384264 |
| 66 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.08363264 |
| 67 | Asymmetric septal hypertrophy (HP:0001670) | 2.07772585 |
| 68 | Elbow flexion contracture (HP:0002987) | 2.07451059 |
| 69 | Right ventricular cardiomyopathy (HP:0011663) | 2.06617917 |
| 70 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06362673 |
| 71 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.03026800 |
| 72 | Ovoid vertebral bodies (HP:0003300) | 2.02742222 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.01882872 |
| 74 | Joint laxity (HP:0001388) | 1.99698718 |
| 75 | Skin nodule (HP:0200036) | 1.99649791 |
| 76 | Nephritis (HP:0000123) | 1.99537367 |
| 77 | Epidermoid cyst (HP:0200040) | 1.99532338 |
| 78 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.99501604 |
| 79 | Abnormal cartilage morphology (HP:0002763) | 1.99384880 |
| 80 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.98690469 |
| 81 | Polycythemia (HP:0001901) | 1.98506887 |
| 82 | Joint stiffness (HP:0001387) | 1.98194311 |
| 83 | Persistence of primary teeth (HP:0006335) | 1.98153594 |
| 84 | Natal tooth (HP:0000695) | 1.97108970 |
| 85 | Loss of speech (HP:0002371) | 1.97004200 |
| 86 | Neonatal short-limb short stature (HP:0008921) | 1.95355353 |
| 87 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.94922301 |
| 88 | Mitral regurgitation (HP:0001653) | 1.93923108 |
| 89 | Spondylolisthesis (HP:0003302) | 1.92867520 |
| 90 | Cerebral inclusion bodies (HP:0100314) | 1.92112580 |
| 91 | Hypoglycemic coma (HP:0001325) | 1.91314487 |
| 92 | Cardiovascular calcification (HP:0011915) | 1.91172912 |
| 93 | Increased density of long bones (HP:0006392) | 1.91137022 |
| 94 | Disproportionate tall stature (HP:0001519) | 1.90994917 |
| 95 | Subacute progressive viral hepatitis (HP:0006572) | 1.90794585 |
| 96 | Syringomyelia (HP:0003396) | 1.90405220 |
| 97 | Spinal cord lesions (HP:0100561) | 1.90405220 |
| 98 | Hyperammonemia (HP:0001987) | 1.90325661 |
| 99 | Hepatocellular carcinoma (HP:0001402) | 1.88814488 |
| 100 | Flared iliac wings (HP:0002869) | 1.88529472 |
| 101 | Abnormal delivery (HP:0001787) | 1.88187465 |
| 102 | Fragile skin (HP:0001030) | 1.88070756 |
| 103 | Hyperextensible skin (HP:0000974) | 1.87740433 |
| 104 | Abnormality of the intrinsic pathway (HP:0010989) | 1.87392039 |
| 105 | Overgrowth (HP:0001548) | 1.87220565 |
| 106 | Abnormality of the acetabulum (HP:0003170) | 1.86251189 |
| 107 | Nonimmune hydrops fetalis (HP:0001790) | 1.85267122 |
| 108 | Wormian bones (HP:0002645) | 1.84819095 |
| 109 | Aortic regurgitation (HP:0001659) | 1.84552801 |
| 110 | Tibial bowing (HP:0002982) | 1.83845283 |
| 111 | Tetraparesis (HP:0002273) | 1.83582437 |
| 112 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.82889061 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 1.81813678 |
| 114 | Abnormality of purine metabolism (HP:0004352) | 1.80938885 |
| 115 | Ectopia lentis (HP:0001083) | 1.80631273 |
| 116 | Chondrocalcinosis (HP:0000934) | 1.79976516 |
| 117 | Hypercholesterolemia (HP:0003124) | 1.79618352 |
| 118 | Wrist flexion contracture (HP:0001239) | 1.78971491 |
| 119 | Emphysema (HP:0002097) | 1.78456559 |
| 120 | Long toe (HP:0010511) | 1.78139568 |
| 121 | Joint hemorrhage (HP:0005261) | 1.77452374 |
| 122 | Bone pain (HP:0002653) | 1.76602265 |
| 123 | Lymphangioma (HP:0100764) | 1.76586616 |
| 124 | Type 1 muscle fiber predominance (HP:0003803) | 1.76459433 |
| 125 | Striae distensae (HP:0001065) | 1.76226797 |
| 126 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.75700697 |
| 127 | Mucopolysacchariduria (HP:0008155) | 1.75700697 |
| 128 | Abnormality of macrophages (HP:0004311) | 1.75289389 |
| 129 | Short nail (HP:0001799) | 1.74518669 |
| 130 | Bladder diverticulum (HP:0000015) | 1.73059169 |
| 131 | Eczematoid dermatitis (HP:0000976) | 1.72816680 |
| 132 | Glomerulonephritis (HP:0000099) | 1.72455135 |
| 133 | Vacuolated lymphocytes (HP:0001922) | 1.72424700 |
| 134 | Hyperparathyroidism (HP:0000843) | 1.72104395 |
| 135 | Thoracolumbar scoliosis (HP:0002944) | 1.71130196 |
| 136 | Hyperlipoproteinemia (HP:0010980) | 1.70455364 |
| 137 | Malnutrition (HP:0004395) | 1.69601788 |
| 138 | Upper limb amyotrophy (HP:0009129) | 1.69574509 |
| 139 | Distal upper limb amyotrophy (HP:0007149) | 1.69574509 |
| 140 | Focal segmental glomerulosclerosis (HP:0000097) | 1.69289053 |
| 141 | Spastic diplegia (HP:0001264) | 1.68348088 |
| 142 | Hemorrhage of the eye (HP:0011885) | 1.67463817 |
| 143 | Impaired platelet aggregation (HP:0003540) | 1.67343003 |
| 144 | Abnormal platelet function (HP:0011869) | 1.67343003 |
| 145 | Fat malabsorption (HP:0002630) | 1.67259256 |
| 146 | Bowed forearm bones (HP:0003956) | 1.66509098 |
| 147 | Bowing of the arm (HP:0006488) | 1.66509098 |
| 148 | Abnormality of dentin (HP:0010299) | 1.65969159 |
| 149 | Alopecia of scalp (HP:0002293) | 1.65563945 |
| 150 | Aortic valve stenosis (HP:0001650) | 1.64547516 |
| 151 | Distal lower limb muscle weakness (HP:0009053) | 1.60111082 |
| 152 | Conjunctival telangiectasia (HP:0000524) | 1.59588205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.15499809 |
| 2 | ERN1 | 3.33282465 |
| 3 | PKN2 | 3.16897353 |
| 4 | LATS1 | 3.01438513 |
| 5 | PRPF4B | 2.48211245 |
| 6 | TTN | 2.47642658 |
| 7 | RIPK1 | 2.18101191 |
| 8 | TAOK2 | 2.06421584 |
| 9 | MAP3K10 | 2.03452462 |
| 10 | EEF2K | 2.01660500 |
| 11 | SIK1 | 2.00247109 |
| 12 | PTK6 | 1.99315609 |
| 13 | PDGFRA | 1.98874059 |
| 14 | MYLK | 1.95581802 |
| 15 | STK10 | 1.89626109 |
| 16 | LRRK2 | 1.89493914 |
| 17 | STK3 | 1.81927849 |
| 18 | DDR2 | 1.75645318 |
| 19 | CDC42BPA | 1.74519098 |
| 20 | NEK9 | 1.69218274 |
| 21 | FRK | 1.68292261 |
| 22 | TAOK3 | 1.66292789 |
| 23 | FGFR4 | 1.48164220 |
| 24 | TYK2 | 1.47577903 |
| 25 | TBK1 | 1.46786389 |
| 26 | RPS6KA4 | 1.44648731 |
| 27 | JAK3 | 1.42909769 |
| 28 | FLT3 | 1.42057819 |
| 29 | TGFBR2 | 1.39898441 |
| 30 | BMX | 1.37767969 |
| 31 | ICK | 1.37628002 |
| 32 | CDK12 | 1.31678785 |
| 33 | LATS2 | 1.30686982 |
| 34 | TRPM7 | 1.22488598 |
| 35 | PTK2 | 1.19304314 |
| 36 | MAP2K3 | 1.18501858 |
| 37 | MAP3K1 | 1.16341835 |
| 38 | MAP4K1 | 1.16039913 |
| 39 | JAK1 | 1.15280864 |
| 40 | CAMK1D | 1.12945586 |
| 41 | EPHB1 | 1.12859278 |
| 42 | GRK7 | 1.12498561 |
| 43 | MST1R | 1.12041426 |
| 44 | PAK4 | 1.09008816 |
| 45 | CDK6 | 1.08250414 |
| 46 | ERBB4 | 1.06061644 |
| 47 | MAP3K14 | 1.05791844 |
| 48 | EPHA2 | 1.05285643 |
| 49 | MAP3K8 | 1.04824380 |
| 50 | BMPR2 | 1.03782895 |
| 51 | PAK2 | 1.01491931 |
| 52 | STK38L | 1.01214140 |
| 53 | TYRO3 | 1.00743284 |
| 54 | KIT | 0.95983330 |
| 55 | PDK2 | 0.95979895 |
| 56 | AKT3 | 0.94111390 |
| 57 | STK24 | 0.91658216 |
| 58 | MAP3K2 | 0.91325258 |
| 59 | SCYL2 | 0.91193102 |
| 60 | BCKDK | 0.90600222 |
| 61 | ARAF | 0.90207083 |
| 62 | NTRK1 | 0.89954642 |
| 63 | MAP3K3 | 0.89691115 |
| 64 | PDGFRB | 0.89169147 |
| 65 | CSF1R | 0.89118787 |
| 66 | NEK2 | 0.87969326 |
| 67 | MTOR | 0.87559013 |
| 68 | MOS | 0.87338822 |
| 69 | MET | 0.86514241 |
| 70 | CSK | 0.86016990 |
| 71 | CHUK | 0.84172360 |
| 72 | CLK1 | 0.81968612 |
| 73 | MATK | 0.80306331 |
| 74 | ABL2 | 0.76422293 |
| 75 | EPHB2 | 0.75183624 |
| 76 | TAOK1 | 0.73829849 |
| 77 | FGR | 0.71801087 |
| 78 | DMPK | 0.67741376 |
| 79 | PIM1 | 0.67611177 |
| 80 | EPHA3 | 0.67149932 |
| 81 | FGFR3 | 0.66613871 |
| 82 | KDR | 0.65120035 |
| 83 | PIK3CG | 0.64672206 |
| 84 | IKBKB | 0.64614481 |
| 85 | CDK4 | 0.63600814 |
| 86 | JAK2 | 0.63022475 |
| 87 | NUAK1 | 0.62843030 |
| 88 | MAPK11 | 0.61832133 |
| 89 | ZAP70 | 0.60889456 |
| 90 | PDPK1 | 0.60430461 |
| 91 | PRKG2 | 0.60317302 |
| 92 | SMG1 | 0.59189094 |
| 93 | CAMK1G | 0.58454451 |
| 94 | TGFBR1 | 0.58409026 |
| 95 | PIM2 | 0.57442973 |
| 96 | RET | 0.56992801 |
| 97 | TIE1 | 0.56795455 |
| 98 | BLK | 0.55393406 |
| 99 | IRAK2 | 0.55373505 |
| 100 | PRKD2 | 0.54994388 |
| 101 | MAPK7 | 0.54519679 |
| 102 | NME2 | 0.53524114 |
| 103 | MAP3K13 | 0.52176719 |
| 104 | MAP2K1 | 0.51358181 |
| 105 | IRAK1 | 0.50957303 |
| 106 | IRAK3 | 0.50824010 |
| 107 | PRKAA2 | 0.50362054 |
| 108 | MAP3K6 | 0.50316398 |
| 109 | GRK6 | 0.50186398 |
| 110 | MELK | 0.49149508 |
| 111 | ABL1 | 0.48928997 |
| 112 | KSR2 | 0.48056408 |
| 113 | WNK1 | 0.47727593 |
| 114 | RPS6KA2 | 0.47030034 |
| 115 | TESK1 | 0.44841811 |
| 116 | TTK | 0.44446970 |
| 117 | MAPKAPK3 | 0.44149503 |
| 118 | CDK9 | 0.44047323 |
| 119 | RPS6KB2 | 0.43473254 |
| 120 | GSK3A | 0.41190595 |
| 121 | MARK2 | 0.40937563 |
| 122 | STK4 | 0.40674575 |
| 123 | MAP3K11 | 0.40391478 |
| 124 | EGFR | 0.40238342 |
| 125 | MAP3K5 | 0.39726504 |
| 126 | DYRK1B | 0.38767577 |
| 127 | BTK | 0.38449092 |
| 128 | ILK | 0.38228876 |
| 129 | MARK3 | 0.38029728 |
| 130 | STK38 | 0.36979390 |
| 131 | IKBKE | 0.36908747 |
| 132 | HCK | 0.36837706 |
| 133 | DAPK3 | 0.35386808 |
| 134 | IRAK4 | 0.34764797 |
| 135 | BRAF | 0.34332385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.83077187 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.39387862 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.38465155 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.31485748 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30207963 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.09409970 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.95761379 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.91821127 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.91005389 |
| 10 | Prion diseases_Homo sapiens_hsa05020 | 1.84816516 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.80065551 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77514242 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70422442 |
| 14 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.48010666 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.45651167 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.44765023 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.44257480 |
| 18 | Salmonella infection_Homo sapiens_hsa05132 | 1.43110819 |
| 19 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40064111 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35712176 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.34697386 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30203387 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.26519013 |
| 24 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21997510 |
| 25 | Lysine degradation_Homo sapiens_hsa00310 | 1.20537247 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19259424 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.18470370 |
| 28 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.17036064 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.15839784 |
| 30 | Hepatitis C_Homo sapiens_hsa05160 | 1.15340595 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.10682333 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.09950443 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.08499666 |
| 34 | Focal adhesion_Homo sapiens_hsa04510 | 1.07699356 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.06937653 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06402395 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.06328583 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05811859 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.04989926 |
| 40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.04922292 |
| 41 | Amoebiasis_Homo sapiens_hsa05146 | 1.04326513 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04173725 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03138137 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 1.02416712 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.02239039 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.02200489 |
| 47 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02084607 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01848568 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00833275 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.99941234 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 0.99311209 |
| 52 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.97135808 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.97026800 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96695099 |
| 55 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95598578 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94705027 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94224846 |
| 58 | Adherens junction_Homo sapiens_hsa04520 | 0.93781089 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92075072 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91584170 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90880665 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89091431 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 0.88114270 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86906365 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.86008619 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.85659577 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.84804496 |
| 68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84778711 |
| 69 | Measles_Homo sapiens_hsa05162 | 0.83516507 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83459413 |
| 71 | Prostate cancer_Homo sapiens_hsa05215 | 0.83238596 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82684293 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82648887 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82200468 |
| 75 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81813603 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81033219 |
| 77 | Phagosome_Homo sapiens_hsa04145 | 0.79519461 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79389433 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.78983318 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78722327 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77258574 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77235819 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77110284 |
| 84 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76942274 |
| 85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76893579 |
| 86 | Retinol metabolism_Homo sapiens_hsa00830 | 0.76569137 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76565489 |
| 88 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.76022448 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.74476817 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74261147 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.73184440 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72879978 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.72477351 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71741362 |
| 95 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.71475818 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.71127685 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70747536 |
| 98 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70407829 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70092240 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70074597 |
| 101 | Legionellosis_Homo sapiens_hsa05134 | 0.69874152 |
| 102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68698539 |
| 103 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68565880 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.68561750 |
| 105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67935097 |
| 106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.67332587 |
| 107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66083959 |
| 108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65864257 |
| 109 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65817802 |
| 110 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65167892 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65003686 |
| 112 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64447442 |
| 113 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.63300752 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63286849 |
| 115 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62706812 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62395837 |
| 117 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.62074296 |
| 118 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.60430348 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60357130 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.60275213 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.59925516 |
| 122 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.59809867 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.59466195 |
| 124 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59213306 |
| 125 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58754639 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58706245 |
| 127 | ABC transporters_Homo sapiens_hsa02010 | 0.58286135 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57858056 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57173438 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.56964445 |
| 131 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56822466 |
| 132 | Glioma_Homo sapiens_hsa05214 | 0.56496962 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56196249 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.54147296 |
| 135 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53949348 |
| 136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53490096 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53060782 |
| 138 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52843411 |
| 139 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.51641818 |
| 140 | Pathways in cancer_Homo sapiens_hsa05200 | 0.51033210 |
| 141 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50286437 |
| 142 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49307690 |
| 143 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47873220 |
| 144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47549615 |
| 145 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47450619 |
| 146 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47433570 |
| 147 | Hepatitis B_Homo sapiens_hsa05161 | 0.47405764 |
| 148 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46431033 |
| 149 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46187138 |
| 150 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46185670 |
| 151 | Viral myocarditis_Homo sapiens_hsa05416 | 0.45273639 |
| 152 | Melanoma_Homo sapiens_hsa05218 | 0.45103168 |
| 153 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.44778774 |

